Japanese subgroup analysis of GLIMMER: a global Phase 2b study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

A Tanaka; M Atsukawa; K Tsuji; K Notsumata; A Suyama; H Ito; Sugato Das; Robyn von Maltzahn; Megan McLaughlin

Japanese subgroup analysis of GLIMMER: a global Phase 2b study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

Translated title of the contribution: Japanese subgroup analysis of GLIMMER: a global Phase 2b study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

A Tanaka
, M Atsukawa
, K Tsuji
, K Notsumata
, A Suyama
, H Ito
, Sugato Das
, Robyn von Maltzahn
, Megan McLaughlin

Research output: Contribution to journal › Article

Translated title of the contribution	Japanese subgroup analysis of GLIMMER: a global Phase 2b study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.
Original language	Undefined/Unknown
Pages (from-to)	629-640
Number of pages	12
Journal	Hepatol Res
Volume	53
Issue number	7
State	Published - Jul 2023

Cite this

@article{fb3da85e667f46a98985596b31952782,

title = "Japanese subgroup analysis of GLIMMER: a global Phase 2b study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.",

author = "A Tanaka and M Atsukawa and K Tsuji and K Notsumata and A Suyama and H Ito and Sugato Das and \{von Maltzahn\}, Robyn and Megan McLaughlin",

year = "2023",

month = jul,

language = "未定義/不明",

volume = "53",

pages = "629--640",

journal = "Hepatol Res",

number = "7",

}

TY - JOUR

T1 - Japanese subgroup analysis of GLIMMER: a global Phase 2b study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

AU - Tanaka, A

AU - Atsukawa, M

AU - Tsuji, K

AU - Notsumata, K

AU - Suyama, A

AU - Ito, H

AU - Das, Sugato

AU - von Maltzahn, Robyn

AU - McLaughlin, Megan

PY - 2023/7

Y1 - 2023/7

M3 - 記事

VL - 53

SP - 629

EP - 640

JO - Hepatol Res

JF - Hepatol Res

IS - 7

ER -